BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
471 results:

  • 1. A novel β-cyclodextrin-assisted enhancement strategy for portable and sensitive detection of miR-21 in human serum.
    Yao F; Wu L; Xiong Y; Su C; Guo Y; Bulale S; Zhou M; Tian Y; He L
    Anal Methods; 2024 Mar; 16(11):1639-1648. PubMed ID: 38414387
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Similar geographic distribution of mortality from multiple sclerosis, Hodgkin lymphoma, and inflammatory bowel disease in the United States.
    Sonnenberg A
    Mult Scler Relat Disord; 2024 Apr; 84():105493. PubMed ID: 38354444
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A case report: Castleman disease treated by the trinity of internal and external treatment of "Fuzheng, phlegm-resolving, and detoxification method".
    Yuan X; Fu H; Xu M; Shen W; Zhou W; Li X; Gan X
    Medicine (Baltimore); 2024 Feb; 103(5):e37110. PubMed ID: 38306555
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Advanced enteropathy-associated T cell lymphoma (EATL) presenting with severe malabsorption and concomitantly diagnosed coeliac disease (CD).
    Rajagopal A; Thompson CA; Chorzempa AK; Ryu AJ
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38142052
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Multimodal ultrasound techniques for the differential diagnosis of splenic lesions - A diagnostic challenge].
    Stock KF; Slotta-Huspenina J; Findeisen H; Görg C
    Chirurgie (Heidelb); 2023 Dec; 94(12):1000-1008. PubMed ID: 38010420
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
    Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
    Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
    Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
    Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma.
    Sonnenberg A; Duong HT; McCarty DJ; El-Serag HB
    Eur J Gastroenterol Hepatol; 2023 Dec; 35(12):1349-1353. PubMed ID: 37942756
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mycosis fungoides with spongiosis: a case report.
    Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
    J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
    Buldini B; Faggin G; Porcù E; Scarparo P; Polato K; Tregnago C; Varotto E; Rizzardi P; Rizzari C; Locatelli F; Biffi A; Pigazzi M
    Cytometry A; 2023 Dec; 103(12):1004-1009. PubMed ID: 37876342
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Flow cytometric signature of CD371-positive B-cell acute lymphoblastic leukemia.
    Shakah H; Tbakhi A; Khudirat S; Abweh RA; Hasasna N; Alwhaidi A; Khoujah A; Barakat F
    J Int Med Res; 2023 Oct; 51(10):3000605231203842. PubMed ID: 37818740
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Leukemia-associated aberrant immunophenotype: A flow cytometry-based experience of 110 cases from a tertiary care center in Northern India.
    Venugopalan RK; Singh N; Anthony ML; Kunnumbrath A; Gupta AK; Nath UK; Chowdhury N; Chandra H
    J Cancer Res Ther; 2023; 19(5):1335-1339. PubMed ID: 37787304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
    Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
    BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Hodgkin lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential diagnosis.
    Yamauchi H; Momoki M; Kamiyama Y; Gunji T; Yokoyama H; Saito T; Boutboul D; Oksenhendler E; Yano S
    Intern Med; 2024 Apr; 63(7):993-998. PubMed ID: 37558474
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Assessment of essential and toxic elemental concentrations in tumor and non-tumor tissues with risk of colorectal carcinoma in Pakistan.
    Qayyum MA; Farooq T; Baig A; Bokhari TH; Anjum MN; Mahmood MH; Ashraf AR; Muddassir K; Ahmad M
    J Trace Elem Med Biol; 2023 Sep; 79():127234. PubMed ID: 37302218
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of characteristics of four patients with adrenal unicentric Castleman disease.
    Yu H; Wang Y; Li Y; Du J; Guo Q; Gu W; Lyu Z; Dou J; Mu Y; Zang L
    Front Endocrinol (Lausanne); 2023; 14():1181929. PubMed ID: 37265694
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hemophagocytic lymphohistiocytosis in inflammatory bowel disease: a nationwide analysis.
    Mahmoud AA; Abdelhay A; Khamis A; Mostafa M; Shehadah A; Mohamed MS; Eltaher B; Malik T
    Ann Hematol; 2023 Jul; 102(7):1705-1711. PubMed ID: 37093242
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular Advances.
    Ivanova M; Bottiglieri L; Sajjadi E; Venetis K; Fusco N
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833303
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Application of modified Matutes score containing CD200 in diagnosis of chronic lymphocytic leukemia.
    Li W; Fang P; Fu G; Liang H; Peng M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1689-1694. PubMed ID: 36748379
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET/CT.
    Li S; Wang H; Wang G; Lu X; Yang J
    Clin Nucl Med; 2023 May; 48(5):445-447. PubMed ID: 36716490
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.